David Patience - 23 Feb 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Chief Financial Officer
Signature
/s/ David Patience
Issuer symbol
TLSI
Transactions as of
23 Feb 2026
Net transactions value
+$14,994
Form type
4
Filing time
23 Feb 2026, 16:08:30 UTC
Previous filing
25 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patience David Chief Financial Officer 6272 W. 91ST AVENUE, WESTMINSTER /s/ David Patience 23 Feb 2026 0001970009

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Purchase $14,994 +3,657 +1.4% $4.10 268,657 23 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.